Anti-oxytocin actions of papaverine, aspaminol and isoprenaline on the rat uterus and intracellular cyclin adenosine 3,5-monophosphate level.
D000818:Animals; D001593:Benzyl Compounds / Q000494:pharmacology; D000440:Butanols / Q000494:pharmacology; D000242:Cyclic AMP / Q000378:metabolism*; D005260:Female; D066298:In Vitro Techniques; D007545:Isoproterenol / Q000494:pharmacology*; D010121:Oxytocin / Q000037:antagonists & inhibitors*; D010208:Papaverine / Q000494:pharmacology*; D010880:Piperidines / Q000494:pharmacology*; D051381:Rats; D014599:Uterus / Q000187:drug effects* / Q000378:metabolism
D001593:Benzyl Compounds; D000440:Butanols; D010880:Piperidines; D010121:Oxytocin; D010208:Papaverine; D000242:Cyclic AMP; D007545:Isoproterenol